Clinical Trials Browser

Interventional × Brain Neoplasms × WP1066 × Clear all

NCT01904123 2022-03-23

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Phase 1 Completed

CNSDermatologic

Brain Neoplasms, Glioblastoma, Glioma, Melanoma